Atrinsic
New York, US · Delaware corporation
Biotech
Founders & leadership
GH
Garo H. ArmenExecutive
AK
Alexander K. ArrowExecutive
Board
KB
Khalil BarrageBoard director
JS
Joshua SilvermanBoard director
GH
Gregory H. EkizianBoard director
RB
Robert B. SteinBoard director
Reported raises · per SEC filings
Form D private placements$5.3M disclosed across 2 rounds · 2016–2019
▶$670KraisedDec 2019 · 14 investors · BiotechnologyRule 506(b)
▶$670KraisedDec 2019 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Garo H ArmenExecutive Officer, Director
- Robert B SteinDirector
- Alexander K ArrowExecutive Officer
- Joshua SilvermanDirector
- Brian J CorveseDirector
- Khalil BarrageDirector
- Offering amount
- $2.5M
- Amount sold
- $670K
- Sales commissions
- $32K
- Placement agents
- Katalyst Securities LLC
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedApr 2016 · 37 investors · BiotechnologyRule 506(b)
▶$4.6MraisedApr 2016 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Garo H. ArmenExecutive Officer, Director
- Alexander K. ArrowExecutive Officer
- Gregory H. EkizianDirector
- Khalil BarrageDirector
- Joshua SilvermanDirector
- Robert B. SteinDirector
- Offering amount
- $5.5M
- Amount sold
- $4.6M
- Sales commissions
- $154.2K
- Placement agents
- Katalyst Securities LLC, WestPark Capital, Inc.
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Atrinsic raised?
- Atrinsic has disclosed $5.3M raised across 2 rounds.
- Where is Atrinsic headquartered?
- Atrinsic is headquartered in New York, US.